andygrove.jpgHaving survived prostate cancer and now facing a mild form of Parkinson’s disease, former Intel chairman Andy Grove has turned his analytical eye on the increasingly dysfunctional U.S. healthcare system.

Grove is a smart guy, however his recommendations are disappointingly small-scale and reflective of the inordinate faith that many high-tech aficionados place in technological “fixes” for complex phenomena. That’s what David Hamilton, writer of VentureBeat Life Sciences argues in his latest look at the healthcare debate.

Note that David is covering daily venture capital investments in healthcare companies. You can bookmark his blog here, or subscribe to his RSS feed here.